Docket Room
SF 2154·IA·senate

A bill for an act relating to the distribution of gene-based vaccines and providing penalties.

In CommitteeFiled Jan 29, 2026
Sponsor: CAMPBELL
Latest Action

Subcommittee: Sweeney, Petersen, and Webster.

Feb 4, 2026

Summary

The bill requires manufacturers of mRNA, DNA or similar gene‑based vaccines to conduct studies on transmissibility, DNA contamination and shedding before the vaccines can be distributed in Iowa. Anyone who distributes a vaccine that the FDA deems to create an unreasonable risk of harm through shedding or transmission could be fined $1,000 per incident and face licensing discipline. Manufacturers also remain liable for injuries caused by design defects.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when SF 2154 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice